Atlas Trials

A Study of TAS-120 in Patients With Metastatic Breast Cancer

Clinical trial NCT04024436 · TERMINATED

Trial details

NCT number
NCT04024436
Sponsor
Taiho Oncology, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast CancerFGFR 1 High AmplificationFGFR2 Amplification
Start date
2020-01-28
Primary completion
2023-05-31
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.